Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Shervin Assassi

Showing results (121-130 of 238) with videos related to

Pageof 24
Sort By:
Arthritis & Rheumatology (Hoboken, N.J.)|April 8, 2024
EphB2 Receptor Promotes Dermal Fibrosis in Systemic SclerosisErika S A Egal, Severin Donald Kamdem, Masaaki Yoshigi, et al.
Arthritis and Rheumatism|October 1, 2009
Clinical and genetic factors predictive of mortality in early systemic sclerosisShervin Assassi, Deborah Del Junco, Kari Sutter, et al.
APL Bioengineering|November 10, 2025
ALK5 inhibitor impact on bleomycin-induced systemic sclerosis mouse model via multifunctional optical coherence tomographyPavel V Nikitin, Harshdeep S Chawla, Jessica Gutierrez, et al.
RMD Open|February 16, 2023
Effect of nintedanib in patients with systemic sclerosis-associated interstitial lung disease and risk factors for rapid progressionDinesh Khanna, Toby M Maher, Elizabeth R Volkmann, et al.
Clinical Rheumatology|August 7, 2017
Ethnicity and disease severity in ankylosing spondylitis a cross-sectional analysis of three ethnic groupsFarokh Jamalyaria, Michael M Ward, Shervin Assassi, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|August 5, 2015
Dissecting the heterogeneity of skin gene expression patterns in systemic sclerosisShervin Assassi, William R Swindell, Minghua Wu, et al.
Arthritis Care & Research|October 26, 2012
Measuring illness behavior in patients with systemic sclerosisErin L Merz, Vanessa L Malcarne, Scott C Roesch, et al.
The Journal of Rheumatology|October 19, 2010
Whole-blood gene expression profiling in ankylosing spondylitis shows upregulation of toll-like receptor 4 and 5Shervin Assassi, John D Reveille, Frank C Arnett, et al.
Frontiers in Immunology|June 4, 2019
OTUD6B-AS1 Might Be a Novel Regulator of Apoptosis in Systemic SclerosisMiki Takata, Elena Pachera, Mojca Frank-Bertoncelj, et al.
Arthritis Research & Therapy|September 4, 2010
Predictors of interstitial lung disease in early systemic sclerosis: a prospective longitudinal study of the GENISOS cohortShervin Assassi, Roozbeh Sharif, Robert E Lasky, et al.
Pageof 24

Showing results (121-130 of 238) with videos related to

Sort By:
Pageof 24
Arthritis & Rheumatology (Hoboken, N.J.)|April 8, 2024
EphB2 Receptor Promotes Dermal Fibrosis in Systemic SclerosisErika S A Egal, Severin Donald Kamdem, Masaaki Yoshigi, et al.
Arthritis and Rheumatism|October 1, 2009
Clinical and genetic factors predictive of mortality in early systemic sclerosisShervin Assassi, Deborah Del Junco, Kari Sutter, et al.
APL Bioengineering|November 10, 2025
ALK5 inhibitor impact on bleomycin-induced systemic sclerosis mouse model via multifunctional optical coherence tomographyPavel V Nikitin, Harshdeep S Chawla, Jessica Gutierrez, et al.
RMD Open|February 16, 2023
Effect of nintedanib in patients with systemic sclerosis-associated interstitial lung disease and risk factors for rapid progressionDinesh Khanna, Toby M Maher, Elizabeth R Volkmann, et al.
Clinical Rheumatology|August 7, 2017
Ethnicity and disease severity in ankylosing spondylitis a cross-sectional analysis of three ethnic groupsFarokh Jamalyaria, Michael M Ward, Shervin Assassi, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|August 5, 2015
Dissecting the heterogeneity of skin gene expression patterns in systemic sclerosisShervin Assassi, William R Swindell, Minghua Wu, et al.
Arthritis Care & Research|October 26, 2012
Measuring illness behavior in patients with systemic sclerosisErin L Merz, Vanessa L Malcarne, Scott C Roesch, et al.
The Journal of Rheumatology|October 19, 2010
Whole-blood gene expression profiling in ankylosing spondylitis shows upregulation of toll-like receptor 4 and 5Shervin Assassi, John D Reveille, Frank C Arnett, et al.
Frontiers in Immunology|June 4, 2019
OTUD6B-AS1 Might Be a Novel Regulator of Apoptosis in Systemic SclerosisMiki Takata, Elena Pachera, Mojca Frank-Bertoncelj, et al.
Arthritis Research & Therapy|September 4, 2010
Predictors of interstitial lung disease in early systemic sclerosis: a prospective longitudinal study of the GENISOS cohortShervin Assassi, Roozbeh Sharif, Robert E Lasky, et al.
Pageof 24